onegentleguy:


@currentprice,
I'll reply you in a bit, let me round off with a meeting 1st.

In the meantime, try to digest the post below;
(it's from a very smart pal in one of the financial forums I belong to)...

There is insane value in GSK, actually.

What they did in 9months can be considered temporary. In Q1 2021, the global supply chain disruption made it difficult to procure raw materials. Hence, production could not take place and revenue had to dip by 30% YoY.
In the subsequent quarters, as most manufacturing coys experienced, there were significantly high costs that eroded margins.

These seem like a temporary problem.
While the operating performance might currently be under pressure, the market price is really at a steep discount.

If you check the statement of financial position as of 9M 2021

Cash stood at N10bn
Net assets was N8bn

While market value is at N7bn - N7.50 bn
Cash alone is greater than market value (for a coy with zero debt)? Nah...

#END

I already summarized this here in the past. (it explains the part about negative Enterprise Value)
But that is just a part of the value potential in GSK.
will revert once am done with my meeting.

klas:

Many thanks brother.
Online Application Process

Visit https://primaryofferng.com/ on your web browser or download "PrimaryOffer" from the Google Play store or Apple store.

Create an account with your BVN and date of birth.

Create a password and verify your account with the One Time Password (“OTP”) sent to you.

Login with your email address and password.

Select MTN Nigeria Offer and “Purchase”.

Specify the number of desired units and select “Pay now”.

Enter your CSCS, clearing house number and bank details for verification.

If you do not have a CSCS account, indicate “No, I don’t” and select “Proceed” to fill the required fields to create a CSCS account.

Input your bank account details and re-insert your password for verification.

Select “Yes” when asked if you have a stockbroker and select a stockbroker that you want as your preferred stockbroker to open your CSCS account.

Review the subscription summary, submit, and make payment as directed.

On successful payment, a notification is sent to your email.

Kabongo1:
I need some advise. I brought NEM some years ago through their sales and I don't know how to request or get my shares. It was through a public offer, in the early 2000s......

Nigerialabalaba:


As u mention prophesy, na so I remember say e get one stock wey nobody don even mention hia and dat stock na hin get next year sure banker. Nobody go buy am if I mention am so make I do peem.

Me, I dey always come and waka in peace like Omo Eko.
Igi pawpaw o ni wo pawa o.

Slimdove:

But I tried the phone number,it is not going through.maybe network. I will continue trying g.

currentprice:
igi ewedu oni wo pawa o

currentprice:


d stock may be one of the the cheapest stock on exchange i was referring to last time cos i see many will not buy with d believe that it overvalued stock few of my ogas here will jump on it when they apply their metric to open the cover on d stock but surprice they haven't mention it yet

the funny thing be say it yet to shed a single tear since bear enter mkt open it time to shed will come soon so as to be more attractive

igi ewedu oni wo pawa o

yMcy56:

Lol.
Igi ogede o ni wo pawa o.

yMcy56:
In my opinion, I think FBNH is a Hold.

As it is now:
** FBNH has large free float with no major control...
** Four major players are battling for the control of FBNH's ship....Otudeko, Adenuga, Otedola and Hassan-Odukale....
** Three major players now owns over 5% shares.......Otedola (5.07%), Otudeko (5.32%), Odukale (5.36%) and Adenuga (over 5% but not sure if this is true because when updated last, it wasn't up to 1%)...
** So far, higher percentages are going into the hands of these billionaires (and many more unmentioned billionaires with less that 1%)..........this is in turn reducing the number of shares available to the public....
** All indications are pointing to more accumulation of shares by the major players to outdo one another in coming days......
** FBNH recently sold her stake in Airtel Nigeria at a premium, amounting to extra cash for the group.....
** If the rumour that Otedola is presently controlling or will be controlling the larger shares is true, then investors are somehow optimistic that FBN will perform so well under his leadership..........considering his past achievements in FO & Geregu plant.....
** These guys are enjoying the backing of the powers-that-be in the background.......
** We may witness more share acquisition in days to come.......
** More drama may likely unfold......
** Just stay tuned.....

currentprice:


d stock may be one of the the cheapest stock on exchange i was referring to last time cos i see many will not buy with d believe that it overvalued stock few of my ogas here will jump on it when they apply their metric to open the cover on d stock but surprice they haven't mention it yet

the funny thing be say it yet to shed a single tear since bear enter mkt ^{hope the stock time time to shed will come soon so as to be more attractive}

igi ewedu oni wo pawa o

currentprice:


d stock may be one of the the cheapest stock on exchange i was referring to last time cos i see many will not buy with d believe that it overvalued stock few of my ogas here will jump on it when they apply their metric to open the cover on d stock but surprice they haven't mention it yet

the funny thing be say it yet to shed a single tear since bear enter mkt ^{hope the stock time time to shed will come soon so as to be more attractive}

igi ewedu oni wo pawa o

Foundwealth001:

The stock you are talking about is not liquid.
Trading at market value of 1.02 with fair value of N34. With no debt in sight , potential future growth and possibility of special dividend declaration in 2023....
The culprit is CWG Plc.
No other entity fit more into this speculation than CWG

currentprice:


d stock may be one of the the cheapest stock on exchange i was referring to last time cos i see many will not buy with d believe that it overvalued stock few of my ogas here will jump on it when they apply their metric to open the cover on d stock but surprice they haven't mention it yet

the funny thing be say it yet to shed a single tear since bear enter mkt ^{hope the stock time time to shed will come soon so as to be more attractive}

igi ewedu oni wo pawa o

DrAwo:


Your post stimulated my interest to looking into the numbers of GSK...

I agree their balance sheet looks attractive as :

1. They are awash with cash (about 10 billion)
2. Have no long term debts which is quite commendable.

The seeming huge cash pile must have come from somewhere though as we know it's a balance sheet. It must balance one way or another.

The didn't sell any property, sell equity or borrow money. However, a look at their liability shows that they are owing their suppliers (trade and other payables) about 14 billion.

In essence, even though they appear cash rich on the balance sheet, the money does not largely belong to them. If you factor this into the consideration for enterprise value, is EV really negative? They may not owe banks but they owe their suppliers...

In my own world, gsk is a good company but it doesn't meet my criteria.

NB: This post is aimed at rubbing minds and learning.

RabbiDoracle:
Look into Betaglass

This is a company that its Q3 2021 EPS is more than the 2020 YE results.

Q3 2021 EPS of N8.33 vs Q3 2020 EPS of N3.74

Q3 2021 EPS of N8.33 vs 2020 YE EPS of N6.93

If 2021 YE EPS come in at N11 or N12, media will easily propagate how Betaglass increased earnings by 70 to 75% and by then prices could go ballastic.

The stock is very illiquid.

DrAwo:

Betaglass that I have been accumulating since time immemorial...

I have always told anyone that cares to listen that Betaglass is an under appreciated well run company that operates almost as a monopoly and is poised for great things...

They have their own issues like being illiquid and a high CapEx but overall, excellent company with long term prospects...

Outsized returns will not come only because of the media lauding their sharp growth (which is mainly due to covid disrupting operations in 2020)... It'll largely come because they are steadily growing, have a huge Moat and are very well managed.

RabbiDoracle:
Buying at cyclical bottoms give superior returns than cryptos. Find those bottoms.

In 2022 and 2023, we will easily see 2,000% to 7,000% in some names on NSE.

All emerging markets need to go parabolic. It will be a bubble of immense proportion.

RabbiDoracle:
Look into Betaglass

This is a company that its Q3 2021 EPS is more than the 2020 YE results.

Q3 2021 EPS of N8.33 vs Q3 2020 EPS of N3.74

Q3 2021 EPS of N8.33 vs 2020 YE EPS of N6.93

If 2021 YE EPS come in at N11 or N12, media will easily propagate how Betaglass increased earnings by 70 to 75% and by then prices could go ballastic.

The stock is very illiquid.

DrAwo:

Betaglass that I have been accumulating since time immemorial...

I have always told anyone that cares to listen that Betaglass is an under appreciated well run company that operates almost as a monopoly and is poised for great things...

They have their own issues like being illiquid and a high CapEx but overall, excellent company with long term prospects...

Outsized returns will not come only because of the media lauding their sharp growth (which is mainly due to covid disrupting operations in 2020)... It'll largely come because they are steadily growing, have a huge Moat and are very well managed.

Calebbold:


Oga DrAwo...pls where can i get that 10 years financial statement chart of Betaglass you posted From?

DrAwo:

I create the charts myself from the companys annual reports sir...
Its worth the trouble to me as it gives me a better view of things...

DrAwo:


Your post stimulated my interest to looking into the numbers of GSK...

I agree their balance sheet looks attractive as :

1. They are awash with cash (about 10 billion)
2. Have no long term debts which is quite commendable.

The seeming huge cash pile must have come from somewhere though as we know it's a balance sheet. It must balance one way or another.

The didn't sell any property, sell equity or borrow money. However, a look at their liability shows that they are owing their suppliers (trade and other payables) about 14 billion.

In essence, even though they appear cash rich on the balance sheet, the money does not largely belong to them. If you factor this into the consideration for enterprise value, is EV really negative? They may not owe banks but they owe their suppliers...

In my own world, gsk is a good company but it doesn't meet my criteria.

NB: This post is aimed at rubbing minds and learning.

RabbiDoracle:


Go further to read about who the supliers are and you will find that they are related party transactions as seen on note 22. They are owing N10b to another company (dem dem) which GSK owns 100%. The actual trade payable is just N548m.

How can this be sorted out?

I have seen this play out in Guinness and Wapco where such related party transactions are converted to shares and given to the parent company and the huge payables cancelled out. I won't be surprised if the parent company demand shares in exchange for cancellation of the payables.

Using TA, GSK is in "squeeze" and once this ends, I see the price going towards N80 long term.

What could cause this to squeeze out?

Mosquirix - the only vaccine approved by WHO which would be used to combat malaria in Africa and any part of the world. I think GSK has the only marketing rights to this vaccine. Google is your friend.

Plant - based Omicron vaccine where GSK is one of the companies whose vaccine can combat omicron in Africa and I learnt is suited for vegetarians since it is extracted from plants.

moneymanager:
In the past few days/weeks I’ve seen many buy recommendations. With advice on due diligence.
It’s not bad to ask people to buy stocks as long as you tell them to do their own research.

Also I will like to add that another thing that can help put things in context is if it’s possible to advice if the recommendation is for long or short term.

I know it’s not always easy to predict stock prices and I’ve great respect for those who get it right from time to time but if you can also add some context with respect to the duration then it might alleviate some stress of people coming to lament in the short term if your advice was for the long term and Vice versa

Again I know it’s not always easy to predict everything 100% but just thought to mention it

Ofcourse the responsibility of this does not rest solely on the shoulders of the guyz making recommendations. Those who wish to follow their advice should also be able to ask more questions like is it a short or long term buy advice etc.